U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07462507) titled 'Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1' on March 04.

Brief Summary: Adult patients with primary or secondary central nervous system malignancies will be invited to undergo a baseline [C-11]-CS1P1 PET scan and a follow-up scan within 24 months of the baseline scan (preferably within 6-months post-treatment).The study will describe patterns of tracer uptake in tumors and normal brain and explore how these patterns relate to MRI findings, treatments received, and clinical outcomes.

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Central Nervous System Ca...